Libing Hu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 10%
- Urinary Bladder and Prostate Research
Papers in
-
- Epigenetics and DNA Methylation 2
- Sexual Differentiation and Disorders 2
- Circular RNAs in diseases 2
- Urology 4
- Urinary Bladder and Prostate Research 4
- Urological Disorders and Treatments 2
- Co-authors
- Yonghong Lei (4 shared papers)Ruiqian Li (4 shared papers)Bin Zhao (3 shared papers)Guoying Zhang (3 shared papers)Zhimin Liu (2 shared papers)Yong Yang (2 shared papers)Aria F. Olumi (4 shared papers)Rongbin Ge (2 shared papers)
- Journals
- The Journal of Urology (2 papers)Cell Metabolism (1 paper)The Prostate (1 paper)Cancer Biomarkers (1 paper)Cellular Signalling (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Libing Hu
12 papers receiving 363 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 133
- Urology 42
- Geriatrics and Gerontology 16
- Molecular Biology 230
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Libing Hu
This map shows the geographic impact of Libing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libing Hu more than expected).
Fields of papers citing papers by Libing Hu
This network shows the impact of papers produced by Libing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libing Hu. The network helps show where Libing Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Libing Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 84 | |
| 2 | 2021 | 71 | |
| 3 | 2007 | 67 | |
| 4 | 2011 | 33 | |
| 5 | 2016 | 27 | |
| 6 | 2017 | 26 | |
| 7 | 2017 | 25 | |
| 8 | 2021 | 15 | |
| 9 | 2019 | 13 | |
| 10 | 2024 | 3 | |
| 11 | 2020 | 1 | |
| 12 | 2017 | 1 |
About Libing Hu
Libing Hu is a scholar working on Molecular Biology, Urology, Pulmonary and Respiratory Medicine, Cancer Research and Physiology, having authored 12 papers that have together received 366 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), Sexual Differentiation and Disorders (2 papers), Circular RNAs in diseases (2 papers), Urological Disorders and Treatments (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (133 citations), Urology (42 citations), Geriatrics and Gerontology (16 citations), Molecular Biology (230 citations) and Pulmonary and Respiratory Medicine (73 citations). Libing Hu has collaborated with scholars based in China and United States. Frequent co-authors include Yonghong Lei, Ruiqian Li, Bin Zhao, Guoying Zhang, Zhimin Liu, Yong Yang, Aria F. Olumi, Rongbin Ge, Zongwei Wang and Chin‐Lee Wu. Their work appears in journals such as The Journal of Urology, Cell Metabolism, The Prostate, Cancer Biomarkers and Cellular Signalling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.